查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1412629

In Silico藥物研發市場：按分子類型、工作流程、治療領域和最終用戶 - 2024-2030 年全球預測

In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年In Silico藥物研發市場規模為26.9億美元，預計2024年將達到28.6億美元，2030年將達到48.3億美元，複合年成長率為8.71%。

In Silico藥物研發的全球市場

主要市場統計
基準年[2023] 26.9億美元
預測年份 [2024] 28.6億美元
預測年份 [2030] 48.3億美元
複合年成長率（%） 8.71%
電腦模擬藥物發現市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估In Silico藥物研發市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對In Silico藥物研發市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-In Silico藥物研發市場的市場規模和預測是多少？

2-在In Silico藥物研發市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3-In Silico藥物研發市場的技術趨勢和法律規範是什麼？

4-In Silico藥物研發市場中主要供應商的市場佔有率是多少？

5-進入In Silico藥物研發市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 疾病盛行率上升和藥物研發
      • 改進計算模型和模擬
      • 個人化醫療方法的趨勢
    • 抑制因素
      • 對資料整合的擔憂
    • 機會
      • 整合先進技術進行In Silico藥物研發
      • 持續研究和開發，推動In Silico藥物研發創新
    • 任務
      • 流程複雜且缺乏熟練的專業人員
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章In Silico類型分類的電腦藥物研發市場

  • 抗體
  • 核酸
  • 胜肽
  • 蛋白質
  • 向量

第 7 章In Silico藥物研發市場：依工作流程

  • 生物資訊學
  • 臨床試驗
  • 發現
  • 臨床前測試
  • 蛋白質結構預測
  • 反向對接
  • 目標識別

第 8 章In Silico藥物研發市場

  • 血液疾病
  • 感染疾病
  • 精神障礙
  • 代謝紊亂
  • 肌肉骨骼疾病
  • 神經系統疾病
  • 腫瘤性疾病
  • 呼吸系統疾病
  • 皮膚病

第 9 章In Silico藥物研發市場：按最終用戶

  • 學術研究所
  • 合約研究組織
  • 藥品製造商

第 10 章 美洲電腦In Silico藥物研發市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區In Silico藥物研發市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的In Silico藥物研發市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Abzena Ltd.
    • Aragen Life Sciences Pvt. Ltd.
    • BioDuro LLC
    • BioNTech SE
    • Certara, Inc.
    • Charles River Laboratories International, Inc.
    • Chemical Computing Group ULC
    • ChemPartner PharmaTech Co Ltd
    • Creative Biostructure
    • Curia Global Inc.
    • Evotec SE
    • GenScript Biotech Corporation
    • InSilico Medicine
    • Ligand Pharmaceuticals Incorporated
    • Schrodinger Inc.
    • Selvita SA
    • Simulations Plus, Inc.
    • Sygnature Discovery
    • Viva Biotech Holding Group
    • WuXi AppTec
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-2E76C3E47FE9

[195 Pages Report] The In-Silico Drug Discovery Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.86 billion in 2024, at a CAGR 8.71% to reach USD 4.83 billion by 2030.

Global In-Silico Drug Discovery Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.86 billion
Forecast Year [2030] USD 4.83 billion
CAGR (%) 8.71%
In-Silico Drug Discovery Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Silico Drug Discovery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Silico Drug Discovery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Silico Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abzena Ltd., Aragen Life Sciences Pvt. Ltd., BioDuro LLC, BioNTech SE, Certara, Inc., Charles River Laboratories International, Inc., Chemical Computing Group ULC, ChemPartner PharmaTech Co Ltd, Creative Biostructure, Curia Global Inc., Evotec SE, GenScript Biotech Corporation, InSilico Medicine, Ligand Pharmaceuticals Incorporated, Schrodinger Inc., Selvita S.A., Simulations Plus, Inc., Sygnature Discovery, Viva Biotech Holding Group, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Silico Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Molecule Type
    • Antibodies
    • Nucleic Acids
    • Peptides
    • Proteins
    • Vectors
  • Workflow
    • Bioinformatics
    • Clinical Trials
    • Discovery
    • Preclinical Tests
    • Protein Structure Prediction
    • Reverse Docking
    • Target Identification
  • Therapeutic Area
    • Blood Disorders
    • Infectious Diseases
    • Mental Disorders
    • Metabolic Disorders
    • Musculoskeletal Disorders
    • Neurological Disorders
    • Oncological Disorders
    • Respiratory Disorders
    • Skin Disorders
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical Manufacturers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In-Silico Drug Discovery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Silico Drug Discovery Market?

3. What are the technology trends and regulatory frameworks in the In-Silico Drug Discovery Market?

4. What is the market share of the leading vendors in the In-Silico Drug Discovery Market?

5. Which modes and strategic moves are suitable for entering the In-Silico Drug Discovery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. In-Silico Drug Discovery Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diseases and increase in drug discovery
      • 5.1.1.2. Improvement in computational models and simulations
      • 5.1.1.3. Inclination towards personalized medicine approach
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with data integration
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in in-silico drug discovery
      • 5.1.3.2. Ongoing R&D to drive innovation in in-silico drug discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Complex process and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. In-Silico Drug Discovery Market, by Molecule Type

  • 6.1. Introduction
  • 6.2. Antibodies
  • 6.3. Nucleic Acids
  • 6.4. Peptides
  • 6.5. Proteins
  • 6.6. Vectors

7. In-Silico Drug Discovery Market, by Workflow

  • 7.1. Introduction
  • 7.2. Bioinformatics
  • 7.3. Clinical Trials
  • 7.4. Discovery
  • 7.5. Preclinical Tests
  • 7.6. Protein Structure Prediction
  • 7.7. Reverse Docking
  • 7.8. Target Identification

8. In-Silico Drug Discovery Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Blood Disorders
  • 8.3. Infectious Diseases
  • 8.4. Mental Disorders
  • 8.5. Metabolic Disorders
  • 8.6. Musculoskeletal Disorders
  • 8.7. Neurological Disorders
  • 8.8. Oncological Disorders
  • 8.9. Respiratory Disorders
  • 8.10. Skin Disorders

9. In-Silico Drug Discovery Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical Manufacturers

10. Americas In-Silico Drug Discovery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In-Silico Drug Discovery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa In-Silico Drug Discovery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abzena Ltd.
    • 14.1.2. Aragen Life Sciences Pvt. Ltd.
    • 14.1.3. BioDuro LLC
    • 14.1.4. BioNTech SE
    • 14.1.5. Certara, Inc.
    • 14.1.6. Charles River Laboratories International, Inc.
    • 14.1.7. Chemical Computing Group ULC
    • 14.1.8. ChemPartner PharmaTech Co Ltd
    • 14.1.9. Creative Biostructure
    • 14.1.10. Curia Global Inc.
    • 14.1.11. Evotec SE
    • 14.1.12. GenScript Biotech Corporation
    • 14.1.13. InSilico Medicine
    • 14.1.14. Ligand Pharmaceuticals Incorporated
    • 14.1.15. Schrodinger Inc.
    • 14.1.16. Selvita S.A.
    • 14.1.17. Simulations Plus, Inc.
    • 14.1.18. Sygnature Discovery
    • 14.1.19. Viva Biotech Holding Group
    • 14.1.20. WuXi AppTec
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. IN-SILICO DRUG DISCOVERY MARKET RESEARCH PROCESS
  • FIGURE 2. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. IN-SILICO DRUG DISCOVERY MARKET DYNAMICS
  • FIGURE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. IN-SILICO DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REVERSE DOCKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 20. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 202. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 203. IN-SILICO DRUG DISCOVERY MARKET LICENSE & PRICING